Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
5 Relatively Safe And Cheap Dividend Stocks To Invest In - March 2023
02:30pm, Saturday, 04'th Mar 2023 Seeking Alpha
In this article, we highlight 5 large-cap, relatively safe, dividend stocks that are offering large discounts to their historical norms. Click here to learn more.
5 Relatively Safe And Cheap Dividend Stocks To Invest In - March 2023
09:30am, Saturday, 04'th Mar 2023
This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying, and are offering large discounts to their historical norms. We go ove
My Dividend Growth Portfolio February Update: Cash Is Not Trash
03:53am, Saturday, 04'th Mar 2023
Cash is yielding over 4%, so a dividend growth investor can afford to be patient. February marked the first monthly decline in projected income since 2016 due to dividend cuts.
The Dividend Pyramid: Potentially Beat The Market With This 12-Stock Portfolio
08:00am, Friday, 03'rd Mar 2023
We start with a discussion of diversification theories based on the findings of a scientific article called "The Dividend Puzzle". While inexperienced investors should stick to ETFs, there's a clear c
This Top Fund Manager Expects A Big Drop In Stocks
07:00am, Friday, 03'rd Mar 2023
Eli Salzmann, manager of the Neuberger Berman Large Cap Value Fund (NPRTX), doesn't expect the early-year stock market rally to last. The post This Top Fund Manager Expects A Big Drop In Stocks appear
5 Best and Worst Performing Mega-Cap Stocks in February 2023
10:55pm, Thursday, 02'nd Mar 2023
After a strong performance in January, the stock market lost pace in the second month of the year.
Investing in Sector ETFs
09:04pm, Thursday, 02'nd Mar 2023 The Motley Fool
A Diversified Strategy
Three-Stock Lunch: JNJ, CVS & D
03:37pm, Thursday, 02'nd Mar 2023
Victoria Green of G Squared Private Wealth joins 'Power Lunch' to discuss stocks hitting new lows, including Johnson & Johnson, CVS Health and Dominion Energy.
Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
02:00pm, Thursday, 02'nd Mar 2023 Zacks Investment Research
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The $3 Million Dividend Growth Portfolio That Could Secure Your Retirement
01:00pm, Thursday, 02'nd Mar 2023 Seeking Alpha
High retirement expectations data shows that the average investor is far from prepared. Click here to find out what makes dividend growth investing so powerful.
Should SPDR Portfolio S&P 500 Value ETF (SPYV) Be on Your Investing Radar?
11:20am, Thursday, 02'nd Mar 2023 Zacks Investment Research
Style Box ETF report for SPYV
Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
10:32am, Thursday, 02'nd Mar 2023
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The $3 Million Dividend Growth Portfolio That Could Secure Your Retirement
08:00am, Thursday, 02'nd Mar 2023
We start by diving into a just-released survey showing high retirement expectations. Unfortunately, data shows that the average investor is far from prepared. Hence, I present a dividend growth portfo
JNJ's Consumer Health Business Separation Will Remove Uncertainty Cloud From Company: Why This Analyst Wants Visibility
07:55pm, Wednesday, 01'st Mar 2023 Benzinga
Guggenheim initiated the coverage on Johnson & Johnson (NYSE: JNJ) with a Neutral rating and a $161 price target.
The analyst agrees with the company's decision to proceed with the Consumer Hea
Jim Cramer Says He's Known Novavax Is 'Worthless' For 'Very Long Time,' Trashes Company For Being Too 'Promotional'
06:21pm, Wednesday, 01'st Mar 2023 Benzinga
Novavax Inc (NASDAQ: NVAX) shares are crashing Wednesday after the company warned that substantial doubt exists regarding its ability to continue.
Jim Cramer isn't surprised.
"I've been saying the
